1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Metastases

Niraparib with abiraterone acetate and prednisone for treating hormone-sensitive metastatic prostate cancer TSID 12044

Awaiting development [GID-TA11558] Expected publication date: TBC

  • Project information
  • Project documents

30385-Niraparib-Abiraterone-Acetate-Prednisone-for-Prostate-Cancer-V1.0-APR2024-NON-CONF.pdf (nihr.ac.uk)